Claris Lifesciences is trading higher by 2% at Rs 202 ahead of board meeting today to consider a share buyback proposal. The board will also consider an interim dividend to exiting equity shareholders.
“The board of directors of the pharmaceutical company will meet on January 07, 2014, to consider, a proposal for buy back of the equity shares of the company,” Claris Lifesciences said in a BSE filing.
Currently, the promoters held 60.21% stake in the company. Foreign institutional investors held 14.77%, followed by domestic institutional investors (11.42%), while the remaining 13.60% stakes are with the individual shareholders and others.
The stock opened at Rs 202 and touched high of Rs 203 on the BSE. Till 0945 hours, around 86,000 shares have changed hands on the counter.
“The board of directors of the pharmaceutical company will meet on January 07, 2014, to consider, a proposal for buy back of the equity shares of the company,” Claris Lifesciences said in a BSE filing.
Currently, the promoters held 60.21% stake in the company. Foreign institutional investors held 14.77%, followed by domestic institutional investors (11.42%), while the remaining 13.60% stakes are with the individual shareholders and others.
The stock opened at Rs 202 and touched high of Rs 203 on the BSE. Till 0945 hours, around 86,000 shares have changed hands on the counter.